-
Lurbinectedin Plus Pembrolizumab May Yield Activity in Relapsed SCLC
05 May 2025 15:27 GMT
… patients with relapsed small cell lung cancer (SCLC), according to findings from … (Hycamtin; 44.4%) and irinotecan (Camptosar; 33.3%) as third-line … with pembrolizumab in small cell lung cancer. (LUPER). ClinicalTrials.gov. Updated February …
-
Lung Cancer Therapeutics Market to Deliver Greater Revenues during the Forecast Period 2024 – 2032
28 Jun 2024 12:03 GMT
… medication access.
Lung Cancer Therapeutics Top … sales milestones.
Lung Cancer Therapeutics Market Segment … Cisplatin
Taxol
Navelbine
Camptosar
Alimta
Distribution Outlook … Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC …
-
Lurbinectedin/Pembrolizumab Shows Significant Activity in Relapsed SCLC
25 Apr 2025 19:05 GMT
… patients with relapsed small cell lung cancer (SCLC), according to data from … (Hycamtin; 44.4%) and irinotecan (Camptosar; 33.3%) as third-line … with pembrolizumab in small cell lung cancer. (LUPER). ClinicalTrials.gov. Updated February …
-
SN Bioscience’s nano-cancer therapy wins orphan drug designation
21 Jul 2023 15:52 GMT
… designation for its small cell lung cancer (SCLC) drug SNB-101, a … other irinotecan drugs.
Pfizer’s Camptosar was the first irinotecan formulation … Society, 10% to 15% of lung cancers are SCLCs. In this condition …
-
Résumé des anticorps conjugués présentés lors de la réunion annuelle de 2023 de l'American Society of Clinical Oncology
10 Jul 2023 11:37 GMT
… puissant que l'irinotécan (Camptosar®), un médicament contre le cancer … -tolerated-preliminary-efficacy-small-cell-lung-cancer-phase) et a été présenté …
-
Summary of Antibody Drug Conjugates (ADCs) Presented at the American Society of Clinical Oncology 2023 Annual Meeting
27 Jun 2023 12:30 GMT
… -decade old cancer drug, irinotecan (Camptosar®) which is a SN-38 … -tolerated-preliminary-efficacy-small-cell-lung-cancer-phase) and presented by Dr …
-
The ADCs of ASCO 2023
23 Jun 2023 13:12 GMT
… -decade old cancer drug, irinotecan (Camptosar®) which is a SN-38 … -tolerated-preliminary-efficacy-small-cell-lung-cancer-phase) and presented by Dr …
About
© 1995-2025